Immunogen (IMGN) Tops Q4 EPS by 4c, FY Revenue Guidance Misses
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $12.27 million.
GUIDANCE:
Immunogen sees FY2019 revenue of $40-45 million, versus the consensus of $84.56 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
